Patterns of gene expression from in utero delivery of adenoviral-associated vector serotype 1

Human Gene Therapy

Volumn 16, Issue 6, 2005, Pages 678-684

  Bilbao, Roberto ^a   Reay, Daniel P ^a   Li, Juan ^b   Xiao, Xiao ^b   Clemens, Paula R ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRAL ASSOCIATED VECTOR SEROTYPE 1; ADENOVIRAL ASSOCIATED VECTOR SEROTYPE 2; ADENOVIRUS VECTOR; BETA GALACTOSIDASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; EMBRYO; FETUS; FETUS CIRCULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; LUNG; MOUSE; NONHUMAN; SEROTYPE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENE; VIRAL GENE THERAPY;

ANIMALS; BETA-GALACTOSIDASE; DEPENDOVIRUS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PREGNANCY; TISSUE DISTRIBUTION; TRANSGENES;

EID: 20844454532     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.678     Document Type: Article

References (21)

1. BILBAO, R., REAY, D.P., HUGHES, T., BIERMANN, V., VOLPERS, C., GOLDBERG, L., BERGELSON, J., KOCHANEK, S., and CLEMENS, P.R. (2003). Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors. Gene Ther. 10, 1821-1829.
2. BILBAO, R., REAY, D.P., WU, E., ZHENG, H., BIERMANN, V., KOCHANEK, S., and CLEMENS, P.R. (2005). Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero. Gene Ther. 12, 39-47.
3. BOUCHARD, S., MACKENZIE, T.C., RADU, A.P., HAYASHI, S., PERANTEAU, W.H., CHIRMULE, N., and FLAKE, A.W. (2003). Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice. J. Gene Med. 5, 941-950.
4. FISHER, K.J., JOOSS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3, 306-312.
5. GAO, G.P., ALVIRA, M.R., WANG, L., CALCEDO, R., JOHNSTON, J., and WILSON, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
6. GREGORY, L.G., WADDINGTON, S.N., HOLDER, M.V., MITROPHANOUS, K.A., BUCKLEY, S.M., MOSLEY, K.L., BIGGER, B.W., ELLARD, P.M., WALMSLEY, L.E., LAWRENCE, L., ALALLAF, F., KINGSMAN, S., COUTELLE, C., and THEMIS, M. (2004). Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy. Gene Ther. 11, 1117-1125.
7. JEREBTSOVA, M., BATSHAW, M.L., and YE, X. (2002). Humoral immune response to recombinant adenovirus and adeno-associated virus after in utero administration of viral vectors in mice. Pediatr. Res. 52, 95-104.
8. LIPSHUTZ, G.S., GRUBER, C.A., CAO, Y., HARDY, J., CONTAG, C.H., and GAENSLER, K.M. (2001). In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression. Mol. Ther. 3, 284-292.
9. MITCHELL, M., JEREBTSOVA, M., BATSHAW, M.L., NEWMAN, K., and YE, X. (2000). Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors. Gene Ther. 7, 1986-1992.
10. RABINOWITZ, J.E., ROLLING, F., LI, C., CONRATH, H., XIAO, W., XIAO, X., and SAMULSKI, R.J. (2002). Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76, 791-801.
11. RUCKER, M., FRAITES, T.J., Jr., PORVASNIK, S.L., LEWIS, M.A., ZOLOTUKHIN, I., CLOUTIER, D.A., and BYRNE, B.J. (2004). Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development 131, 3007-3019.
12. SAMULSKI, R.J., SRIVASTAVA, A., BERNS, K.I., and MUZYCZKA, N. (1983). Rescue of adeno-associated virus from recombinant plasmids: Gene correction within the terminal repeats of AAV. Cell 33, 135-143.
13. SCHACHTNER, S.K., BUCK, C.A., BERGELSON, J.M., and BALDWIN, H.S. (2003). Temporally regulated expression patterns following in utero adenovirus-niediated gene transfer. Gene Ther. 6, 1249-1257.
14. SCHNEIDER, H., MUHLE, C., DOUAR, A.M., WADDINGTON, S., JIANG, Q.J., VON DER MARK, K., COUTELLE, C., and RASCHER, W. (2002). Sustained delivery of therapeutic concentrations of human clotting factor IX-a comparison of adenoviral and AAV vectors administered in utero. J. Gene Med. 4, 46-53.
15. WADDINGTON, S.N., BUCKLEY, S.M., NIVSARKAR, M., JEZZARD, S., SCHNEIDER, H., DAHSE, T., KEMBALL-COOK, G., MIAH, M., TUCKER, N., DALLMAN, M.J., THEMIS, M., and COUTELLE, C. (2003a). In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous denting factor. Blood 101, 1359-1366.
16. WADDINGTON, S.N., MITROPHANOUS, K.A., ELLARD, F.M., BUCKLEY, S.M., NIVSARKAR, M., LAWRENCE, L., COOK, H.T., AL-ALLAF, F., BIGGER, B., KINGSMAN, S.M., COUTELLE, C., and THEMIS, M. (2003b). Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immune-competent mice. Gene Ther. 10, 1234-1240.
17. WADDINGTON, S.N., NIVSARKAR, M.S., MISTRY, A.R., BUCKLEY, S.M., KEMBALL-COOK, G., MOSLEY, K.L., MITROPHANOUS, K., RADCLIFFE, P., HOLDER, M.V., BRITTAN, M., GEORGIADIS, A., AL-ALLAF, F., BIGGER, B.W., GREGORY, L.G., COOK, H.T., ALI, R.R., THRASHER, A., TUDDENHAM, E.G., THEMIS, M., and COUTELLE, C. (2004). Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood 104, 2714-2721.
18. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108.
19. XIAO, X., LI, J., and SAMULSKI, R.J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.
20. XIAO, W., CHIRMULE, N., BERTA, S.C., MCCULLOUGH, B., GAO, G., and WILSON, J.M. (1999). Gene therapy vectors based on adeno-associated virus type 1. J. Virol. 73, 3994-4003.
21. YANG, E.Y., KIM, H.B., SHAABAN, A.F., MILNER, R., ADZICK, N.S., and FLAKE, A.W. (1999). Persistent postnatal transgene expression in both muscle and liver after fetal injection of recombinant adenovirus. J. Pediatr. Surg. 34, 766-772.